Form 8-K - Current report:
SEC Accession No. 0001104659-24-108591
Filing Date
2024-10-15
Accepted
2024-10-15 16:16:03
Documents
13
Period of Report
2024-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425951d2_8k.htm   iXBRL 8-K 24238
  Complete submission text file 0001104659-24-108591.txt   195272

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA twst-20241008.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20241008_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20241008_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2425951d2_8k_htm.xml XML 3553
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 241372022
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)